143 related articles for article (PubMed ID: 13151339)
1. [Chemotherapy of malignant hematological diseases].
SANCHEZ MEDAL L
Gac Med Mex; 1953; 83(6):443-51. PubMed ID: 13151339
[No Abstract] [Full Text] [Related]
2. Recent developments in the treatment of hemopoietic and lymphoid neoplasms.
Flexner JM
J Tenn Med Assoc; 1977 Jan; 70(1):13-6. PubMed ID: 319299
[No Abstract] [Full Text] [Related]
3. [P-bis-(beta-chloroethyl) aminophenylalanine (sarcolysin) in antiblastic chemotherapy with special reference to lymphatic blood diseases].
LOVISETTO P; CASTELLANO M
Haematologica; 1958; 43(4):261-324. PubMed ID: 13548671
[No Abstract] [Full Text] [Related]
4. [The use of thymostimulin in lymphoma and myeloma patients].
Cánovas Fernández A; Alonso Alonso J; González de Zárate P; García Masdevall MD; Riñón Martínez-Gallo M; Aguirre Errasti C
An Med Interna; 1991 Feb; 8(2):69-73. PubMed ID: 1893006
[TBL] [Abstract][Full Text] [Related]
5. [Status and trends in hematology].
Stobbe H
Z Arztl Fortbild (Jena); 1986; 80(18):741-4. PubMed ID: 3544527
[No Abstract] [Full Text] [Related]
6. [Chemotherapy in lymphoma & leukemia].
SILVA MS
Rev Paul Med; 1957 Mar; 50(3):190-5. PubMed ID: 13442166
[No Abstract] [Full Text] [Related]
7. [Chemotherapy in lymphoma & leukemia; indication & limitations].
ROSENFELD G
Rev Paul Med; 1957 Mar; 50(3):186-90. PubMed ID: 13442165
[No Abstract] [Full Text] [Related]
8. Care of the patient with malignant lymphoma.
Hays K; Rafferty DC
Nurs Clin North Am; 1982 Dec; 17(4):677-95. PubMed ID: 6817308
[No Abstract] [Full Text] [Related]
9. Intensive therapy for medical complications of haematological malignancy at the Royal Marsden Hospital.
Banerjee A; Lakhani S; McElwain TJ; Powles R
Intensive Care Med; 1987; 13(3):213-4. PubMed ID: 3584651
[No Abstract] [Full Text] [Related]
10. Chemotherapy of the leukemias and lymphomas.
STICKNEY JM
Minn Med; 1954 Apr; 37(4):275-7. PubMed ID: 13154166
[No Abstract] [Full Text] [Related]
11. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias.
MEZA ARRAU C; NIJAMKIN A
Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308
[No Abstract] [Full Text] [Related]
12. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
Imamura Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):934-41. PubMed ID: 3694002
[No Abstract] [Full Text] [Related]
13. Present status and future problems of interferon in the treatment of hematological malignancies.
Kimura K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1677-87. PubMed ID: 2425532
[No Abstract] [Full Text] [Related]
14. [Long-term therapy in leukemias and malignant lymphomas].
Aul C; Schneider W
Fortschr Med; 1983 Feb; 101(7):275-82. PubMed ID: 6840654
[No Abstract] [Full Text] [Related]
15. [Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions].
INTROZZI P; MARINONE G
Haematologica; 1953; 37(11):1195-1274. PubMed ID: 13151517
[No Abstract] [Full Text] [Related]
16. Recent publications in hematological oncology.
Hematol Oncol; 2002 Mar; 20(1):43-50. PubMed ID: 11921016
[No Abstract] [Full Text] [Related]
17. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
18. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances].
Testa U
Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843
[TBL] [Abstract][Full Text] [Related]
19. Recent publications in hematological oncology.
Hematol Oncol; 2007 Sep; 25(3):148-55. PubMed ID: 17957827
[No Abstract] [Full Text] [Related]
20. TRIETHYLENE-MELAMINE.
Br Med J; 1955 Jun; 1(4926):1380-1. PubMed ID: 14363905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
